Mapping Immune Responses to CMV in Renal Transplantation

CMV is one of the most problematic pathogens in the immunocompromised host after solid organ and stem cell transplantation, increasing morbidity and mortality risk, and graft loss. Approaches for improved understanding and subsequent harnessing of the host immune response to CMV are needed to reduce the burden of CMV complications in immunocompromised individuals, including chronic injury of the transplanted organ.